Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: Systemic review and meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 10, 2014, Pages 3150-3163

  Yi, Hui Ming ^a   Zhang, Wei ^a   Ai, Xi ^a   Li, Kai Yan ^a   Deng, You Bin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatocellular carcinoma; Meta analysis; Milan criteria; Radiofrequency ablation; Surgical resection

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; LAPAROSCOPIC SURGERY; LIVER CELL CARCINOMA; LIVER RESECTION; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PUBLISHING; QUALITY CONTROL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RISK ASSESSMENT; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84910041761     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Szumera-Cieckiewicz A, Olszewski WT, Piech K, Glogowski M and Prochorec-Sobieszek M. Endobronchial metastasis from hepatocellular carcinoma: a case description with literature review. Int J Clin Exp Pathol 2013; 6: 1942-1947.
2. El-Serag HB and Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Eng J Med 1999; 340: 745-750.
3. Hennedige T and Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging 2013; 12: 530-547.
4. Marin-Hargreaves G, Azoulay D and Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 2003; 47: 13-27.
5. Xia QY, Liu S, Li FQ, Huang WB, Shi LN and Zhou XJ. Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters. Int J Clin Exp Pathol 2013; 6: 1610-1616.
6. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C and Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-89.
7. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010; 78: 113-124.
8. Lencioni R and Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012; 262: 43-58.
9. Xiong X, Shao W, Yin W, Xu X, Chen H, Qiu Y and He J. Video-assisted thoracoscopic surgery for stage I non-small cell lung cancer: long-term survival and prognostic factors. Tumor Biol 2013; 34: 3389-3396.
10. Takayama T, Makuuchi M, Hasegawa K. Single HCC smaller than 2 cm: surgery or ablation?: surgeon's perspective. J Hepatobiliary Pancreatic Sci 2010; 17: 422-424.
11. Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y and Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903-912.
12. Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, Cavallari A. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102-107.
13. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328.
14. Hsu HH, Cheng LH, Ho TJ, Kuo WW, Lin YH, Chen MC, Lee NH, Tsai FJ, Tsai KH and Huang CY. Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote prosruvival capability via IGF-IR/PI3K/Akt signaling pathway activation. Tumor Biol 2014; 35: 303-313.
15. Shabanzadeh DM and Sorensen LT. Laparo-scopic surgery compared with open surgery decreases surgical site infection in obese patients: a systematic review and meta-analysis. Ann Surg 2012; 256: 934-945.
16. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M and Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
18. Montorsi M, Santambrogio R, Bianchi P, Donadon M, Moroni E, Spinelli A and Costa M. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005; 9: 62-67.
19. Ogihara M, Wong LL and Machi J. Radiofre-quency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes. HPB (Oxford) 2005; 7: 214-221.
20. Gao W, Chen MH, Yan K, Yang W, Sun Y and Xing BC. Therapeutic effect of radiofrequency ablation in unsuitable operative small hepatocellular carcinoma. Chin J Med Imaging Technol 2007; 23: 254-257.
21. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A and Memeo V. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 2007; 9: 429-434.
22. Zhou T, Chou YD, Kong WT, Zhang WW and Ding YT. Comparing the effect of Radiofre-quency ablation and surgical resection for the treatment of small hepatocellular. J Hepatobiliary Surg 2007; 15: 424-427.
23. Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW and Nicoli N. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008; 12: 1521-1526.
24. Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y, Ninomiya T, Otomi Y, Kokame M, Iwamura T, Ishimaru Y, Sogabe I, Kashihara K, Nishiura S, Ootani H, Takamura K, Kawasaki H. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 2008; 55: 2171-2174.
25. Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009; 16: 359-366.
26. Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T, Arimoto A, Osaki Y. Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 2011; 11: 143.
27. Yun WK, Choi MS, Choi D, Rhim HC, Joh JW, Kim KH, Jang TH, Lee JH, Koh KC, Paik SW, Yoo BC. Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 2011; 5: 722-729.
28. Imai K, Beppu T, Chikamoto A, Doi K, Okabe H, Hayashi H, Nitta H, Ishiko T, Takamori H, Baba H. Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res 2013; 43: 853-864.
29. Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP and Shi M. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 2012; 262: 1022-1033.
30. Wong KM, Yeh ML, Chuang SC, Wang LY, Lin ZY, Chen SC, Tsai JF, Wang SN, Kuo KK, Dai CY, Yu ML, Lee KT, Chuang WL. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma. Indian J Gastroenterol 2013; 32: 253-257.
31. Desiderio J, Trastulli S, Pasquale R, Cavaliere D, Cirocchi R, Boselli C, Noya G, Parisi A. Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up. Langenbecks Arch Surg 2013; 398: 55-62.
32. Lai EC and Tang CN. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria-A comparative study. Int J Surg 2013; 11: 77-80.
33. Tohme S, Geller DA, Cardinal JS, Chen HW, Packiam V, Reddy S, Steel J, Marsh JW, Tsung A. Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. HPB (Oxford) 2013; 15: 210-217.
34. Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC, Naveau S. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17: 1247-1261.
35. Bruix J and Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 4: 1208-1236.
36. Racz GB and Ruiz-Lopez R. Radiofrequency procedures. Pain Pract 2006; 6: 46-50.
37. Lencioni R and Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 2007; 10: 38-46.
38. Valls C, Ruiz S, Barrau V, Burdio F, Llado L, Figueras J, Vilgrain V. Radiofrequency ablation of hepatic tumors. Radiology 2006; 48: 53-69.
39. Machi J, Uchida S, Sumida K, Limm WM, Hundahl SA, Oishi AJ, Furumoto NL, Oishi RH. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001; 5: 477-489.
40. Rahbari NN, Mehrabi A, Mollberg NM, Muller SA, Koch M, Buchler MW, Weitz J. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011; 253: 453-469.
41. Bruix J and Sherman M. Manegement of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
42. Liu L, Miao R, Yang H, Lu X, Zhao Y, Mao Y, Zhong S, Huang J, Sang X, Zhao H. Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China. Am J Surg 2012; 203: 741-750.
43. Kohles N, Nagel D, Jungst D, Durner J, Stieber P and Holdenrieder S. Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therap. Tumor Biol 2012; 33: 33-40.
44. Grat M, Holowko W, Grzegorczyk K, Skalski M and Krawczyk M. Long-term results of liver resection in the treatment of patients with hepatocellular carcinoma. Pol Przegl Chir 2011; 83: 319-324.
45. Shi M, Zhang CQ, Zhang YQ, Liang XM and Li JQ. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 2004; 28: 376-381.
46. Wong IH, Yeo W, Leung T, Lau WY and Johnson PJ. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. Cancer Lett 2001; 167: 183-191.
47. Liu CH, Arellano RS, Uppot RN, Samir AE, Gervais DA and Mueller PR. Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Euro Radiol 2010; 20: 877-885.
48. Kim YS, Rhim H, Cho OK, Koh BH and Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 2006; 59: 432-441.
49. Wakai T, Shirai Y, Suda T, Yokoyama N, Sakata J, Cruz PV, Kawai H, Matsuda Y, Watanabe M, Aoyagi Y, Hatakeyama K. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm. World J Gastroenterol 2006; 12: 546-552.
50. Ke S, Ding XM, Kong J, Gao J, Wang SH, Cheng Y, Sun WB. Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma. J Transl Med 2010; 8: 73.
51. Okuwaki Y, Nakazawa T, Shibuya A, Ono K, Hidaka H, Watanabe M, Kokubu S and Saigenji K. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol 2008; 43: 71-78.
52. Lau WY and Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009; 249: 20-25.
53. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJ and Steme JA. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008; 336: 601-605.